nodes	percent_of_prediction	percent_of_DWPC	metapath
Foscarnet—SLC22A6—Hydrochlorothiazide—nephrolithiasis	0.693	1	CbGbCtD
Foscarnet—SLC22A6—Organic anion transport—SLC22A12—nephrolithiasis	0.0381	0.237	CbGpPWpGaD
Foscarnet—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0177	0.11	CbGpPWpGaD
Foscarnet—SLC16A1—Basigin interactions—SLC7A9—nephrolithiasis	0.0134	0.0834	CbGpPWpGaD
Foscarnet—Electrolyte imbalance—Hydrochlorothiazide—nephrolithiasis	0.00774	0.0529	CcSEcCtD
Foscarnet—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00547	0.034	CbGpPWpGaD
Foscarnet—Serum creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.00526	0.0359	CcSEcCtD
Foscarnet—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00509	0.0316	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—SLC7A9—nephrolithiasis	0.00446	0.0277	CbGpPWpGaD
Foscarnet—Ventricular arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00437	0.0299	CcSEcCtD
Foscarnet—Gamma-glutamyltransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00393	0.0269	CcSEcCtD
Foscarnet—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.00365	0.025	CcSEcCtD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00359	0.0223	CbGpPWpGaD
Foscarnet—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00355	0.0221	CbGpPWpGaD
Foscarnet—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.00349	0.0238	CcSEcCtD
Foscarnet—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.0033	0.0205	CbGpPWpGaD
Foscarnet—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.00329	0.0225	CcSEcCtD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00328	0.0204	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00328	0.0204	CbGpPWpGaD
Foscarnet—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.00305	0.0209	CcSEcCtD
Foscarnet—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.00292	0.02	CcSEcCtD
Foscarnet—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.00267	0.0183	CcSEcCtD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00249	0.0155	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00249	0.0155	CbGpPWpGaD
Foscarnet—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.00247	0.0169	CcSEcCtD
Foscarnet—Thirst—Hydrochlorothiazide—nephrolithiasis	0.00247	0.0169	CcSEcCtD
Foscarnet—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.00236	0.0161	CcSEcCtD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00233	0.0145	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00231	0.0144	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00231	0.0144	CbGpPWpGaD
Foscarnet—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00227	0.0155	CcSEcCtD
Foscarnet—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.00221	0.0151	CcSEcCtD
Foscarnet—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.0022	0.015	CcSEcCtD
Foscarnet—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00214	0.0146	CcSEcCtD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00213	0.0132	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00213	0.0132	CbGpPWpGaD
Foscarnet—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.00211	0.0145	CcSEcCtD
Foscarnet—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00211	0.0145	CcSEcCtD
Foscarnet—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00207	0.0142	CcSEcCtD
Foscarnet—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00207	0.0142	CcSEcCtD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00206	0.0128	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00205	0.0127	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00205	0.0127	CbGpPWpGaD
Foscarnet—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00203	0.0139	CcSEcCtD
Foscarnet—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00199	0.0136	CcSEcCtD
Foscarnet—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.0019	0.013	CcSEcCtD
Foscarnet—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.0019	0.013	CcSEcCtD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00182	0.0113	CbGpPWpGaD
Foscarnet—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00179	0.0123	CcSEcCtD
Foscarnet—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00178	0.0122	CcSEcCtD
Foscarnet—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00177	0.0121	CcSEcCtD
Foscarnet—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00176	0.012	CcSEcCtD
Foscarnet—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00176	0.012	CcSEcCtD
Foscarnet—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00172	0.0118	CcSEcCtD
Foscarnet—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.0017	0.0116	CcSEcCtD
Foscarnet—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00169	0.0115	CcSEcCtD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00167	0.0104	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00167	0.0104	CbGpPWpGaD
Foscarnet—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00163	0.0111	CcSEcCtD
Foscarnet—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00162	0.011	CcSEcCtD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00161	0.01	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00161	0.01	CbGpPWpGaD
Foscarnet—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00161	0.011	CcSEcCtD
Foscarnet—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00154	0.0105	CcSEcCtD
Foscarnet—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00151	0.0103	CcSEcCtD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.0015	0.00933	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.0015	0.00933	CbGpPWpGaD
Foscarnet—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00139	0.00952	CcSEcCtD
Foscarnet—Tension—Hydrochlorothiazide—nephrolithiasis	0.00139	0.00948	CcSEcCtD
Foscarnet—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00137	0.00939	CcSEcCtD
Foscarnet—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00137	0.00935	CcSEcCtD
Foscarnet—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00136	0.00929	CcSEcCtD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00134	0.00832	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00133	0.00825	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00133	0.00825	CbGpPWpGaD
Foscarnet—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00132	0.00905	CcSEcCtD
Foscarnet—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00131	0.00897	CcSEcCtD
Foscarnet—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00131	0.00893	CcSEcCtD
Foscarnet—Agitation—Hydrochlorothiazide—nephrolithiasis	0.0013	0.00888	CcSEcCtD
Foscarnet—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00127	0.00872	CcSEcCtD
Foscarnet—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00127	0.00865	CcSEcCtD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00126	0.00786	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00126	0.00786	CbGpPWpGaD
Foscarnet—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00125	0.00854	CcSEcCtD
Foscarnet—Cough—Hydrochlorothiazide—nephrolithiasis	0.00123	0.00843	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—SLC7A9—nephrolithiasis	0.00121	0.00752	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—DGKH—nephrolithiasis	0.00121	0.00752	CbGpPWpGaD
Foscarnet—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.0012	0.00823	CcSEcCtD
Foscarnet—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.0012	0.00823	CcSEcCtD
Foscarnet—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.0012	0.00823	CcSEcCtD
Foscarnet—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.0012	0.0082	CcSEcCtD
Foscarnet—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00119	0.00813	CcSEcCtD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00118	0.00736	CbGpPWpGaD
Foscarnet—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00118	0.00805	CcSEcCtD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00118	0.0073	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00118	0.0073	CbGpPWpGaD
Foscarnet—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00116	0.00795	CcSEcCtD
Foscarnet—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00115	0.00789	CcSEcCtD
Foscarnet—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00113	0.00772	CcSEcCtD
Foscarnet—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00112	0.00762	CcSEcCtD
Foscarnet—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.0011	0.00752	CcSEcCtD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00108	0.00673	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00108	0.00673	CbGpPWpGaD
Foscarnet—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00108	0.00737	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00105	0.00719	CcSEcCtD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00105	0.00651	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00105	0.00651	CbGpPWpGaD
Foscarnet—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00104	0.00713	CcSEcCtD
Foscarnet—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00104	0.00708	CcSEcCtD
Foscarnet—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00103	0.00703	CcSEcCtD
Foscarnet—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00103	0.00701	CcSEcCtD
Foscarnet—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00102	0.00694	CcSEcCtD
Foscarnet—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.001	0.00686	CcSEcCtD
Foscarnet—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.000995	0.0068	CcSEcCtD
Foscarnet—Pain—Hydrochlorothiazide—nephrolithiasis	0.000987	0.00674	CcSEcCtD
Foscarnet—Constipation—Hydrochlorothiazide—nephrolithiasis	0.000987	0.00674	CcSEcCtD
Foscarnet—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.000951	0.0065	CcSEcCtD
Foscarnet—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.000943	0.00645	CcSEcCtD
Foscarnet—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.000912	0.00624	CcSEcCtD
Foscarnet—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.000912	0.00624	CcSEcCtD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000837	0.0052	CbGpPWpGaD
Foscarnet—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.000828	0.00566	CcSEcCtD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00082	0.0051	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00082	0.0051	CbGpPWpGaD
Foscarnet—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.000816	0.00558	CcSEcCtD
Foscarnet—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.000789	0.0054	CcSEcCtD
Foscarnet—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.000763	0.00522	CcSEcCtD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000763	0.00474	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000763	0.00474	CbGpPWpGaD
Foscarnet—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.000734	0.00501	CcSEcCtD
Foscarnet—Rash—Hydrochlorothiazide—nephrolithiasis	0.000727	0.00497	CcSEcCtD
Foscarnet—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.000727	0.00497	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—GRHPR—nephrolithiasis	0.000726	0.00451	CbGpPWpGaD
Foscarnet—Headache—Hydrochlorothiazide—nephrolithiasis	0.000723	0.00494	CcSEcCtD
Foscarnet—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000685	0.00469	CcSEcCtD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00068	0.00423	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00068	0.00423	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—AGXT—nephrolithiasis	0.000647	0.00402	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—APRT—nephrolithiasis	0.00055	0.00342	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—SLC26A1—nephrolithiasis	0.00055	0.00342	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000543	0.00338	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—AQP1—nephrolithiasis	0.000392	0.00244	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CHRM3—nephrolithiasis	0.000355	0.0022	CbGpPWpGaD
